Inositol 1,3,4,5-Tetrakisphosphate Negatively Regulates Phosphatidylinositol-3,4,5- Trisphosphate Signaling in Neutrophils  by Jia, Yonghui et al.
Immunity
ArticleInositol 1,3,4,5-Tetrakisphosphate Negatively
Regulates Phosphatidylinositol-3,4,5-
Trisphosphate Signaling in Neutrophils
Yonghui Jia,1 Kulandayan K. Subramanian,1 Christophe Erneux,2 Valerie Pouillon,2 Hidenori Hattori,1
Hakryul Jo,1 Jian You,1 Daocheng Zhu,1 Stephane Schurmans,2 and Hongbo R. Luo1,*
1Department of Pathology, Harvard Medical School, Dana-Farber/Harvard Cancer Center, Department of Lab Medicine,
Children’s Hospital Boston, Karp Family Research Building, Room 10214, Boston, MA 02115, USA
2IRIBHM, Universite´ Libre de Bruxelles, rue des Professeurs Jeener et Brachet 12, 6041 Gosselies, Belgium
*Correspondence: hongbo.luo@childrens.harvard.edu
DOI 10.1016/j.immuni.2007.07.016SUMMARY
Many neutrophil functions are regulated
by phosphatidylinositol-3,4,5-trisphosphate
(PtdIns(3,4,5)P3) that mediates protein mem-
brane translocation via binding to pleckstrin ho-
molog (PH) domains within target proteins. Here
we show that inositol 1,3,4,5-tetrakisphosphate
(Ins(1,3,4,5)P4), a cytosolic small molecule,
bound the same PH domain of target proteins
and competed for binding to PtdIns(3,4,5)P3. In
neutrophils, chemoattractant stimulation trig-
gered rapid elevation in Ins(1,3,4,5)P4 concen-
tration. Depletion of Ins(1,3,4,5)P4 by deleting
the gene encoding InsP3KB, which converts
Ins(1,4,5)P3 to Ins(1,3,4,5)P4, enhanced mem-
brane translocation of the PtdIns(3,4,5)P3-
specific PH domain. This led to enhanced sensi-
tivity to chemoattractant stimulation, elevated
superoxide production, and enhanced neutro-
phil recruitment to inflamed peritoneal cavity.
On the contrary, augmentation of intracellular
Ins(1,3,4,5)P4concentrationblockedPHdomain-
mediated membrane translocation of target pro-
teins and dramatically decreased the sensitivity
of neutrophils to chemoattractant stimulation.
These findings establish a role for Ins(1,3,4,5)P4
in cellular signal transduction pathways and
provide another mechanism for modulating
PtdIns(3,4,5)P3 signaling in neutrophils.
INTRODUCTION
Inositol phosphates are phosphate esters of a 6-carbon
sugar found in many animal and plant tissues (Irvine and
Schell, 2001; Shears, 2004). More than 25 inositol phos-
phates were identified in eukaryotic cells, with the most
extensively characterized being inositol 1,4,5-trisphos-
phate (Ins(1,4,5)P3 or IP3), which releases calcium from
intracellular storage (Berridge, 1993; Irvine and Schell,
2001). Ins(1,4,5)P3 can be converted to Ins(1,3,4,5)P4 byIma family of inositol trisphosphate kinases (InsP3K) includ-
ing InsP3KA, InsP3KB, and InsP3KC (Choi et al., 1990;
Dewaste et al., 2002; Nalaskowski et al., 2003). Higher
inositol phosphates containing energetic pyrophosphate
bonds have also been described, especially diphosphoi-
nositol pentakisphosphate (pp-InsP5 or InsP7) and bis-
diphosphoinositol tetrakisphosphate (bis-pp-InsP4 or InsP8)
(Irvine and Schell, 2001; Shears, 2004). InsP7 is formed by
a family of inositol hexakisphosphate kinases (InsP6K)
including InsP6K1, InsP6K2, and InsP6K3 (Saiardi et al.,
2000; Schell et al., 1999). Cellular functions for most cyto-
solic inositol phosphates are still ill defined.
By using Dictyostelium discoideum as a model system,
we recently established InsP7 as a negative regulator of
PtdIns(3,4,5)P3 signaling pathway (Luo et al., 2003b).
PtdIns(3,4,5)P3 is an essential mediator in Dictyostelium
chemotaxis and exerts its function by mediating mem-
brane translocation of target proteins via binding to their
pleckstrin homolog (PH) domains (Bourne and Weiner,
2002; Funamoto et al., 2001; Iijima et al., 2002; Lemmon,
2003; Parent and Devreotes, 1999; Ridley et al., 2003;
Stephens et al., 2002). We demonstrated InsP7-medi-
ated physiologic regulation of Dictyostelium chemotaxis
by its competition with PtdIns(3,4,5)P3 for binding PH
domain-containing proteins. In the same study, we no-
ticed that Ins(1,3,4,5)P4 binds PH domains with a simi-
lar affinity. In Dictyostelium, InsP7 is the major negative
regulator because its intracellular concentration is about
100 times higher than that of Ins(1,3,4,5)P4 (Luo et al.,
2003b).
PtdIns(3,4,5)P3 is involved in a variety of cellular
processes such as cell survival, proliferation, growth, dif-
ferentiation, polarization, chemotaxis, cytoskeletal rear-
rangement, and membrane trafficking and therefore has
become a promising therapeutic target for cancers and
neurological and inflammatory diseases. Its concentration
is regulated by phosphatidylinositol 30-kinases (PI3 kinase
or PI3K) (Cantley, 2002; Cantrell, 2001; Rodgers and
Theibert, 2002; Vivanco and Sawyers, 2002), the tumor
suppressor PTEN (Di Cristofano and Pandolfi, 2000;
Maehama and Dixon, 1999; Myers et al., 1998; Stambolic
et al., 1998), SH-2-containing Inositol 50 Phosphatase
(SHIP), and phosphoinositide-specific inositol polyphos-
phate 5-phosphatase IV (5ptase IV) (Astle et al., 2007;munity 27, 453–467, September 2007 ª2007 Elsevier Inc. 453
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Ins(1,3,4,5)P4 Function in NeutrophilsKisseleva et al., 2002). PtdIns(3,4,5)P3 signaling was pre-
viously thought to be dependent solely upon the concen-
tration of PtdIns(3,4,5)P3 in the membrane. Our studies in
Dictyostelium provided another layer of regulation for this
signaling process, namely relative concentrations of InsP7
and PtdIns(3,4,5)P3 (Luo et al., 2003b). Nevertheless,
whether a similar mechanism also exists in mammalian
cells has not been investigated. To test this, we utilized
neutrophils in which a variety of cellular functions are
mediated by PtdIns(3,4,5)P3.
Neutrophils constitute the first line of host defense
against invading microorganisms. In response to inflam-
matory stimuli, they migrate from the circulation to infected
tissues, where they protect their host by phagocytosing,
killing, and digesting bacterial and fungal pathogens
(Bokoch, 1995; Olson and Ley, 2002). Many neutrophil
functions are mediated by PtdIns(3,4,5)P3. For example,
a variety of chemoattractants, such as bacteria-released
formyl-peptides, some complement fragments, and che-
mokines, could bind to cell-surface G protein-coupled
receptors (GPCR) and induce the dissociation of G protein
into a and bg subunits. The released bg subunits initiate
the activation of PI3K, causing membrane accumulation
of PtdIns(3,4,5)P3. A subset of PH domain-containing
proteins are rapidly recruited to the plasma membrane
through their specific binding with PtdIns(3,4,5)P3 and trig-
ger downstream signaling pathways leading to various
cellular events such as polymerization of F-actin, formation
of new lamellipodia or pseudopods, polarization, chemo-
taxis, and superoxide formation (Gardiner et al., 2002;
Ridley et al., 2003; Stephens et al., 2002; Xu et al., 2003;
Zigmond, 1989).
In current study, we investigated the role of inositol
phosphates in regulating PtdIns(3,4,5)P3 signaling in
neutrophils. Our data demonstrate that Ins(1,3,4,5)P4,
by blocking PtdIns(3,4,5)P3-mediated plasma membrane
translocation of PH domain-containing proteins, serves
as a physiological negative regulator of a variety of
PtdIns(3,4,5)P3-mediated neutrophil functions.
RESULTS
Chemoattractant Stimulation Rapidly Increases
Ins(1,3,4,5)P4, but Not InsP7 Concentration,
in Neutrophils
Our previous data showed that InsP7 and Ins(1,3,4,5)P4
have a similar potency in inhibiting PtdIns(3,4,5)P3-PH
domain binding in an in vitro liposome cosedimentation
assay (Luo et al., 2003b). In D. discoideum, InsP7 is the
predominant inositol phosphate, and its concentrations
are tightly regulated by chemotactic signaling, supporting
the idea of its role as the major negative regulator. To ex-
amine the role of inositol phosphate in neutrophils, we first
measured the concentration of individual inositol phos-
phates in neutrophils upon chemoattractant stimulation.
Primary neutrophils are terminally differentiated cells with
a short in vivo life span of 24–48 hr, which makes this
system unsuitable for labeling endogenous inositol high
phosphates (InsP6, InsP7, and InsP8) with [3H]inositol.454 Immunity 27, 453–467, September 2007 ª2007 Elsevier IncIncorporation of [3H]inositol into these inositol phosphates
would not reach plateau values until 3–4 days after the
addition of [3H]inositol (Europe-Finner et al., 1991; Stuart
et al., 1994). In order to detect InsP6 and InsP7, we utilized
a human promyelocytic cell line, HL60, which can be in-
duced to differentiate toward morphologically mature
neutrophils by incubation with compounds such as dime-
thylsulfoxide (DMSO) or retinoic acid (RA). The differenti-
ated cells possess many of the functional characteristics
of normal neutrophils including receptor-dependant che-
motactic response to formyl-peptides. Thus, this system
has been widely used and well accepted as a model sys-
tem for studying neutrophil responses to chemoattractant
stimulation (Servant et al., 2000; Wang et al., 2002; Xu
et al., 2003).
We labeled endogenous stores of inositol phosphates in
HL60 cells with [3H]inositol and monitored their concentra-
tions upon chemoattractant stimulation (Figures 1A and
1B). Consistent with previous results (Bradford and Rubin,
1986; French et al., 1991; Stuart et al., 1994), our data
showed that Ins(1,3,4,5)P4 is the major isoform of InsP4
in neutrophils (data not shown). We observed pronounced
elevation of intracellular Ins(1,3,4,5)P4 in response to
formyl-Met-Leu-Phe (fMLP), a tripeptide widely used as a
model chemoattractant in studies of neutrophil functions.
Concentrations of Ins(1,3,4,5)P4 increased 7- to 8-fold
after fMLP application, whereas InsP7 was undetectable
even after fMLP stimulation. Responses are rapid with
maximal stimulation at 60 s and half maximal effects at
40 s (Figure 1B). fMLP-elicited Ins(1,3,4,5)P4 production
was also detected in human primary neutrophils (Figure S1
in the Supplemental Data available online). These results
strongly suggests that Ins(1,3,4,5)P4, instead of InsP7, is
the major negative regulator of PtdIns(3,4,5)P3 signaling
in neutrophils.
Ins(1,4,5)P3 Kinase Activity Is Enhanced upon
Chemoattractant Stimulation in Neutrophils
Ins(1,3,4,5)P4 issynthesizedby the InsP3K enzymes,which
convert Ins(1,4,5)P3 to Ins(1,3,4,5)P4 (Irvine and Schell,
2001; Michell, 2002; Shears, 2004). Disruption of these ki-
nases leads to depletion of intracellular Ins(1,3,4,5)P4
(Jun et al., 1998; Pouillon et al., 2003). Accordingly, we
examined the enzymatic activity of endogenous InsP3K
in chemoattractant-stimulated and -unstimulated neutro-
phils. We observed a rapid and pronounced increase of
InsP3K activity in response to fMLP treatment (Figure 1C).
The kinase from untreated neutrophils converted less than
15% of Ins(1,4,5)P3 to Ins(1,3,4,5)P4, whereas the kinase
from cells treated with fMLP for 2 min converted more
than 80%. These results are consistent with the regulatory
role of InsP3Ks in mediating chemoattractant-elicited
signals.
Ins(1,3,4,5)P4 Negatively Regulates
Chemoattractant-Elicited PH Domain Membrane
Translocation in Neutrophils
The upregulation of Ins(1,3,4,5)P4 upon chemoattractant
stimulationsuggests that Ins(1,3,4,5)P4mightphysiologically.
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Ins(1,3,4,5)P4 Function in NeutrophilsFigure 1. Chemoattractant-Elicited Ins(1,3,4,5)P4 Upregulation in Neutrophils
(A) fMLP rapidly augments Ins(1,3,4,5)P4 concentration in neutrophil-like differentiated HL60 cells. All the data were normalized to the total amount of
protein extracted from each sample.
(B) The amounts of Ins(1,3,4,5)P4 were plotted as a function of time after chemoattractant stimulation.
(C) Ins(1,4,5)P3 kinase activity is enhanced upon fMLP stimulation in primary neutrophils. Purified mouse neutrophils were stimulated with 100 nM
fMLP. The left panel is [3H]InsP3 substrate alone. The kinase assays were performed in the presence of saturating substrate and were linear over
time (data not shown), so that increases in catalytic activity most likely represent changes in Vmax.
Data are presented as mean values from three independent experiments whose results varied less than 5%.inhibit neutrophil function by blocking PtdIns(3,4,5)P3-
mediated PH domain translocation, which is a key step in
the PtdIns(3,4,5)P3 signaling pathway. Therefore we exam-
ined whether translocation of PH domains to the plasma
membrane-associated PtdIns(3,4,5)P3 in intact neutro-
phils is altered by elevating intracellular Ins(1,3,4,5)P4 con-
centration. Ins(1,3,4,5)P4 is a highly hydrophilic molecule
and cannot passively cross the plasma membrane; there-
fore, the intracellular concentration of Ins(1,3,4,5)P4 can-
not be raised by simply adding Ins(1,3,4,5)P4 in culture
medium. To circumvent this problem, we utilized a mem-
brane-permeant derivative of Ins(1,3,4,5)P4, D-2,6-di-O-
butyryl-myo-inositol 1,3,4,5-tetrakis-phosphate octakisa-
cetoxymethyl ester (Bt2Ins(1,3,4,5)P4-AM) (Figure S3).
Bt2Ins(1,3,4,5)P4-AM diffuses into cells and is subse-
quently hydrolyzed by ubiquitous, nonspecific cellular
esterases to release Ins(1,3,4,5)P4. This method has been
previously used by other labs to increase endogenous
Ins(1,3,4,5)P4 concentration (Collins et al., 2000; Cozier
et al., 2000; Eckmann et al., 1997).
We first evaluated the membrane translocation of PH
domain by measuring the degree of endogenous Akt
phosphorylation. Akt contains a PtdIns(3,4,5)P3-specific
PH domain and can be recruited onto the plasma mem-
brane via its specific binding to PtdIns(3,4,5)P3. Only the
Akt molecules on the plasma membrane can be phos-Imphorylated by two phosphatidylinositol-dependent pro-
tein kinases (PDK) and get activated (Cantley, 2002; Sar-
bassov et al., 2005; Shaw and Cantley, 2006). Inhibitors
of Akt plasma membrane translocation decrease the de-
gree of Akt phosphorylation that can be easily monitored
by immunoblot analysis with a phospho-Akt-specific anti-
body (Luo et al., 2003a). This system has been utilized in
previous studies and Akt phosphorylation has been proven
to be an authentic representative of PtdIns(3,4,5)P3-medi-
ated PH domain plasma membrane translocation (Huang
et al., 2003; Servant et al., 2000; Wang et al., 2002). We ex-
amined the effect of Bt2Ins(1,3,4,5)P4-a.m. on Akt phos-
phorylation in both differentiated HL60 cells (Figure 2A)
and primary neutrophils (Figure 2B). The degree of Akt
phosphorylation increased dramatically after fMLP stimu-
lation. Bt2Ins(1,3,4,5)P4-AM inhibited the fMLP-induced
Akt phosphorylation, whereas Bt2Ins(1,3,4,6)P4-AM (a
membrane-permeant Ins(1,3,4,6)P4 that does not bind
to PH domain) was inactive.
We also used the PH domain of Akt (PHAkt) fused with
green fluorescent protein (PHAkt-GFP) as a marker to di-
rectly visualize chemoattractant-elicited PH domain trans-
location. Although PHAkt-GFP translocates to the leading
edge of chemotaxing cells in chemotactic gradient, during
uniform treatment with chemoattractant it transiently
translocates from cytosol to the plasma membrane (Parentmunity 27, 453–467, September 2007 ª2007 Elsevier Inc. 455
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Ins(1,3,4,5)P4 Function in NeutrophilsFigure 2. Ins(1,3,4,5)P4 Inhibits PtdIns(3,4,5)P3 Signaling by Blocking PH Domain Membrane Translocation
(A) Ins(1,3,4,5)P4 inhibits fMLP-induced Akt phosphorylation in differentiated HL60 cells. Cells were treated with 50 mM Bt2Ins(1,3,4,5)P4-AM or
Bt2Ins(1,3,4,6)P4-AM at 37C for 15 min and then uniformly stimulated with 100 nM fMLP for 40 s.
(B) Ins(1,3,4,5)P4 inhibits fMLP-induced Akt phosphorylation in mouse primary neutrophils.
(C) Ins(1,3,4,5)P4 inhibits fMLP-induced PH domain membrane translocation in differentiated HL60 cells. HL60 cells stably expressing PHAkt-GFP
were differentiated, treated with Bt2Ins(1,3,4,5)P4-AM as described above, and then uniformly stimulated with 100 nM fMLP.
(D–F) Ins(1,3,4,5)P4 negatively regulates neutrophil chemotaxis. Mouse neutrophils were plated on fibronectin-coated coverslips and treated with
Bt2Ins(1,3,4,5)P4-AM as described above. Time-lapse images of chemotaxing neutrophils were recorded as described in Figure S2.
(D) Positions of cells relative to their initial positions after 10 min incubation in a gradient of chemotactic peptide fMLP.
(E) Cell distribution is the percentage of cells that ended up within a 120 arc facing the source of chemoattractant (the areas between the two dash
lines in [D]). This number reflects the directionality of chemotaxing cells.
(F) Chemotaxis speed is the speed of neutrophils moving up a chemotactic gradient (Dd/t. d, distance between a cell and the micropipette; t, migration
time).
Twenty cells were examined and the results are the means (±SD) of three independent experiments. *p < 0.01 versus untreated cells by Student’s
t test.and Devreotes, 1999; Servant et al., 2000). We explored
the translocation of PHAkt-GFP to the membrane of intact
differentiated HL60 cells that stably express PHAkt-GFP
in response to uniform stimulation (Figure 2C). With a
saturating concentration of fMLP (100 nM), membrane
translocation of PHAkt-GFP occurred instantaneously and
peaked within 10–20 s. Membrane translocation was
completely inhibited by Bt2Ins(1,3,4,5)P4-AM, whereas
Bt2Ins(1,3,4,6)P4-AM is essentially inactive. This result fur-
ther demonstrates that Ins(1,3,4,5)P4, by inhibiting the
membrane translocation of PH domain-containing pro-
teins, negatively regulated PtdIns(3,4,5)P3 signaling.
Ins(1,3,4,5)P4 Negatively Regulates
Neutrophil Chemotaxis
PtdIns(3,4,5)P3-mediated PH domain plasma membrane
translocation is a crucial step in chemotactic signaling
(Bourne and Weiner, 2002; Ferguson et al., 2007). There-
fore, we examined whether chemotactic responses of
neutrophils can be inhibited by Bt2Ins(1,3,4,5)P4-AM.
Mouse primary neutrophils were isolated from bone mar-
rows and the cell movement was recorded by time-lapse456 Immunity 27, 453–467, September 2007 ª2007 Elsevier Incmicroscopy. We measured both chemotaxis directionality
and speed of Bt2Ins(1,3,4,5)P4-AM-treated neutrophils
(Figures 2D–2F). Chemotaxis was induced by a point
source of chemotactic peptide fMLP-Flu (Figure S2).
More than 80% of untreated neutrophils move toward
higher concentrations of chemoattractant, compared to
only about 30% of neutrophils treated with 50 mM
Bt2Ins(1,3,4,5)P4-AM. As a control, Bt2Ins(1,3,4,6)P4-
AM failed to disrupt the directionality of chemotaxing cells
(Figures 2D and 2E). Chemotaxis speed was also clearly
reduced by the treatment of Bt2Ins(1,3,4,5)P4-AM
Bt2Ins(1,3,4,5)P4-AM-treated neutrophils (0.2 mm/min)
migrate up the fMLP-Flu gradient 6 times slower than
untreated (1.2 mm/min) or Bt2Ins(1,3,4,6)P4-AM-treated
(1.3 mm/min) neutrophils (Figure 2F). In the experiments
described above, we utilized 50 mM Bt2Ins(1,3,4,5)P4-
AM, because this is the routinely used concentration
(50–200 mM) for this type of compound (Collins et al., 2000;
Cozier et al., 2000; Eckmann et al., 1997). Similar inhibitory
effects were observed when 10 mM compounds were uti-
lized. The chemotaxis directionality and speed of primary
neutrophils treated with 10 mM Bt2Ins(1,3,4,5)P4-AM are.
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Ins(1,3,4,5)P4 Function in NeutrophilsFigure 3. Ins(1,3,4,5)P4 Associates with PH Domain in Differentiated Neutrophil-like HL60 Cells
HL60 cells stably expressing PHAkt-GFP were differentiated and labeled with [
3H]inositol. After being stimulated with 100 nM fMLP for 1 min,
PHAkt-GFP associated inositol phosphates were pulled down by GFP antibody, extracted, and analyzed by HPLC as described in Figure 1.43% and 0.43 mm/min, respectively (data not shown).
Taken together, the neutrophil chemotactic migration
was substantially inhibited by Ins(1,3,4,5)P4.
Ins(1,3,4,5)P4 Directly Associates with PH Domain
in Differentiated HL60 Cells
We proved that Ins(1,3,4,5)P4 effectively blocks
PtdIns(3,4,5)P3-mediated PH domain membrane translo-
cation. To demonstrate that this inhibition is mediated by
direct binding of Ins(1,3,4,5)P4 to PH domain, we explored
interaction of Ins(1,3,4,5)P4 with PH domain in intact cells
(Figure 3). We utilized a HL60 cell line stably expressing
PHAkt-GFP fusion protein. Cells were differentiated and
labeled with [3H]inositol for 6 days and the resulting
neutrophil-like cells were stimulated with 100 nM fMLP
for 1 min. Radiolabeled inositol phosphates associated
with PHAkt-GFP fusion protein were coimmunoprecipi-
tated by GFP antibody and analyzed by HPLC.
[3H]InsP6, [3H]InsP5, and [3H]Ins(1,3,4,5)P4 associate
with precipitated PHAkt-GFP, whereas these substancesImdo not precipitate in the presence of preimmune serum
or in cells expressing GFP only. The supernatant of immu-
noprecipitated PHAkt-GFP sample contains substantial
levels of [3H]InsP6 and [3H]InsP5 but relatively low levels
of Ins(1,3,4,5)P4 in contrast to the much greater levels of
Ins(1,3,4,5)P4 compared to InsP6 and InsP5 in the immu-
noprecipitate, suggesting that the binding affinity between
Ins(1,3,4,5)P4 and PH domain is much higher than that
between InsP5/InsP6 and PH domain. In summary, this
finding substantiates the selective association of
Ins(1,3,4,5)P4 with PH domain-containing proteins.
InsP3KB Is the Major Isoform of InsP3 Kinase
in Neutrophils
InsP3K catalyzes the phosphorylation of Ins(1,4,5)P3 to
Ins(1,3,4,5)P4. In mammalian cells, there are three iso-
forms of InsP3K, designated A, B, and C. All three isoforms
have been cloned (Choi et al., 1990; Dewaste et al., 2002;
Nalaskowski et al., 2003). They share a well-conserved
carboxy-terminal catalytic domain, an inositol-bindingmunity 27, 453–467, September 2007 ª2007 Elsevier Inc. 457
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gene encoding InsP3KA is expressed exclusively in spe-
cific neuronal subpopulations in the central nervous sys-
tem and in testis. The genes encoding isoforms B and
C are expressed fairly ubiquitously (Dewaste et al., 2002;
Nalaskowski et al., 2003; Vanweyenberg et al., 1995).
InsP3KB is the major isoform in T cells, as shown by the
fact that disruption of this isoform in mice led to a strong
diminution of Ins(1,3,4,5)P4 production in T cells (Pouillon
et al., 2003). To determine which InsP3K isoform(s) are
expressed in neutrophils, we conducted an immunoblot
analysis to monitor the protein expression of each individ-
ual InsP3K (Figure 4A). Like in T cells, InsP3KB was the ma-
jor InsP3K isoform in both human and mouse neutrophils.
InsP3KA and InsP3KC were essentially undetectable.
These results are consistent with recent microarray data
that also showed that InsP3KB is much more abundant
than the other two isoforms in neutrophils (Theilgaard-
Monch et al., 2005).
PtdIns(3,4,5)P3 Signaling Is Enhanced in InsP3KB
Null Neutrophils
InsP3KB is the only InsP3 kinase detected in neutrophils,
so we utilized a InsP3KB-deficient mouse to isolate neu-
trophils depleted of Ins(1,3,4,5)P4. Immunoblot analysis
confirms the complete depletion of InsP3KB protein in
neutrophils purified from this mouse (Figure 4B).
InsP3KB-deficient neutrophils displayed similar size, mor-
phology, and density as wild-type neutrophils (Figure S5).
In these neutrophils, InsP5 and InsP2 are still formed, but
fMLP-induced InsP4 production is completely abolished
(Figure 4C). We monitored the effect of Ins(1,3,4,5)P4
depletion on fMLP-elicited PtdIns(3,4,5)P3 signaling by
measuring phosphorylation of Akt (Figures 4D and 4E).
Before chemoattractant stimulation, Akt phosphorylation
was virtually undetectable in both wild-type and
InsP3KB-deficient neutrophils. Upon stimulation, WT neu-
trophils showed maximum Akt phosphorylation at 30 s,
which then declined marginally by 5 min. Akt phosphory-
lation was substantially augmented in InsP3KB-deficient
neutrophils at every time point examined, although the
time course for the increase and subsequent decrease is
not altered (Figures 4D and 4E).
One important downstream effect of chemoattractant-
induced PtdIns(3,4,5)P3 production in neutrophils is actin
polymerization. Therefore, we subsequently examined the
dynamics of actin polymerization by measuring the
amount of F-actin after fMLP stimulation. Upon stimula-
tion with 1 mM fMLP, F-actin levels increased dramatically
in both WT and InsP3KB-deficient neutrophils within 1 min
(Figure 4F; Figure S6). However, the increase was more
pronounced in InsP3KB-deficient neutrophils than in WT
neutrophils. As time progressed, F-actin levels in WT neu-
trophils declined substantially by 5 min. InsP3KB-deficient
neutrophils exhibited a similar decline as did WT neutro-
phils (Figure 4F). These results are consistent with the
role of Ins(1,3,4,5)P4 as a negative regulator of chemoat-
tractant-induced PtdIns(3,4,5)P3 synthesis.458 Immunity 27, 453–467, September 2007 ª2007 Elsevier IncInsP3KB Is Localized in the Leading Edge
of Polarized Neutrophils
Enzyme activity can sometimes be regulated by its sub-
cellular localization. In chemotaxis, many signaling events
take place locally. For example, Rac-related signaling and
actin polymerization are detected at the leading edge of
chemotaxing cells, whereas Rho GTPase activation and
contractile actin-myosin complexes appear only at the
back of the cells (Ridley et al., 2003; Bourne and Weiner,
2002; Stephens et al., 2002). Knowing the localization of
a protein and the signaling events happening near this
protein will help us to further understand its regulation
and function. Because InsP3 kinase activity can be highly
regulated by chemoattractant stimulation (Figure 1) and
InsP3KB is the major isoform of InsP3 kinase in neutro-
phils (Figure 4A), we investigated whether chemoattrac-
tant treatment can regulate the intracellular localization
of InsP3KB in neutrophils. A construct expressing an
InsP3KB protein fused with EGFP (InsP3KB-EGFP) was
delivered into mouse primary neutrophils with a Nucleo-
fection technique (Figure 4G). Similar with F-actin,
InsP3KB was localized in the leading edge of polarized
neutrophils after fMLP stimulation. As a control, EGFP ap-
peared more uniformly localized in the fMLP-stimulated
polarized neutrophils. Although partially colocalized with
F-actin in the leading edge, it was also detected at the
back of the polarized cells where F-actin is absent. This
result further substantiates a role of InsP3KB in regulating
chemotactic signaling.
InsP3KB-Deficient Neutrophils Exhibit
an Enhanced Superoxide Production
Activation of PtdIns(3,4,5)P3 signaling pathway is also re-
quired for chemoattractant-elicited NADPH oxidase acti-
vation and superoxide production. Thus, we investigated
whether depleting Ins(1,3,4,5)P4 can elevate superoxide
production in neutrophils. fMLP- and C5a-induced super-
oxide production in InsP3KB-deficient and wild-type neu-
trophils was detected by isoluminol chemiluminescence.
As expected, InsP3KB-deficient neutrophils displayed
much enhanced superoxide production compared to
wild-type neutrophils (Figures 5A and 5C–5F). When
treated with phorbol-12-myristate-13-acetate (PMA), a
PKC activator, InsP3KB-deficient neutrophils generated
almost the same amount of superoxide as wild-type neu-
trophils (Figures 5B and 5G), indicating that the enhanced
superoxide production in InsP3KB-deficient neutrophils is
specific for PtdIns(3,4,5)P3-mediated signals. We have
also examined whether neutrophil priming can further ele-
vate superoxide production in fMLP- and C5a-stimulated
InsP3KB-deficient neutrophils. Neutrophil priming is an
important feature of neutrophil inflammatory response.
In this process, pretreatment with inflammatory factors
such as LPS and TNFa dramatically augments superoxide
production in response to chemoattractants such as C5a
and fMLP. This phenomenon allows neutrophils to tightly
control time and amplitude of superoxide production.
Both fMLP- and C5a-stimulated InsP3KB-deficient neu-
trophils displayed enhanced superoxide production after.
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Ins(1,3,4,5)P4 Function in NeutrophilsFigure 4. Depletion of Ins(1,3,4,5)P4 Enhances PtdIns(3,4,5)P3 Signaling in Neutrophils
(A and B) InsP3KB is the major isoform of InsP3 kinase in neutrophils. All InsP3K antibodies can recognize both human (A) and mouse (B) InsP3
kinases. We used recombinant InsP3K proteins (1 ng/lane) as positive controls.
(C) Chemoattractant-elicited Ins(1,3,4,5)P4 production was abolished in InsP3KB null neutrophils. The data presented are n-fold increases of
Ins(1,3,4,5)P4 and total inositol signals (free inositol, IP, IP2, IP3, IP4, IP5, and IP6) 1 min after fMLP stimulation. Ins(1,3,4,5)P4 only counts for less
than 0.01% of the total inositol signal, and therefore the difference of Ins(1,3,4,5)P4 level will not lead to obvious difference of total inositol level.
(D and E) The level of phospho-Akt is elevated in InsP3KB null neutrophils. Neutrophils were stimulated with 1 mM fMLP for indicated time and phos-
phorylated Akt was detected by western blot. Relative amounts of phosphorylated Akt were quantified with NIH Image software as previously de-
scribed (Luo et al., 2002). Results are the means (±SD) of three independent experiments. *p < 0.01 versus wild-type neutrophils by Student’s t test.
(F) Enhanced actin polymerization in InsP3KB-deficient neutrophils. Neutrophils were stimulated with 1 mM fMLP for indicated time, fixed, and stained
with 0.13 mg/ml of fluorescein phalloidin. Results are the means (±SD) of three independent experiments. **p < 0.01 versus wild-type neutrophils by
Student’s t test; *p < 0.05 versus wild-type neutrophils.
(G) InsP3KB is localized in the leading edge of polarized neutrophils. Wild-type mouse primary neutrophils were transfected with a construct express-
ing InsP3KB-EGFP or EGFP (as a control) by a Nucleofector Kit (see Supplemental Experimental Procedures). Neutrophils were stimulated with
100 nM fMLP for 5 min, fixed, and stained with rhodamine-phalloidin and 4’,6-diamidino-2-phenylindole (DAPI) as previously described (Subramanian
et al., 2007). The figures show the results of a representative experiment.Immunity 27, 453–467, September 2007 ª2007 Elsevier Inc. 459
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Ins(1,3,4,5)P4 Function in NeutrophilsFigure 5. Enhanced Superoxide Production in InsP3KB-Deficient Neutrophils
(A–F) Bone marrow-derived neutrophils (43 105) were stimulated with indicated chemoattractants directly (A, C, E) or after primed with LPS (D and F)
for 1 hr. In (B), neutrophils were stimulated with 200 nM PMA. Kinetics of superoxide release was monitored with a luminometer at 37C. RLU, relative
light units. Results are the means (±SD) of three independent experiments. *p < 0.01 versus wild-type neutrophils by Student’s t test.
(G) Comparison of superoxide production between WT and InsP3KB-deficient neutrophils. Shown is the n-fold increase of superoxide production
compared to wild-type neutrophils (normalized to 1) after indicated stimulation. Data are the mean (±SD) of three independent experiments.
*p < 0.01 versus wild-type neutrophils by Student’s t test.
(H) Ins(1,3,4,5)P4 inhibits fMLP-induced superoxide production in both wild-type and InsP3KB-deficient neutrophils. Bone marrow-derived neutro-
phils were treated with 20 mM Bt2Ins(1,3,4,5)P4-AM or Bt2Ins(1,4,5,6)P4-AM at 37C for 15 min and then uniformly stimulated with 100 nM fMLP.460 Immunity 27, 453–467, September 2007 ª2007 Elsevier Inc.
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deficient neutrophils is somewhat less pronounced than
that observed in wild-type neutrophils (Figure 5G). This is
probably because the superoxide synthesis in primed
InsP3KB-deficient neutrophils is already very close to
maximal.
Because InsP3K converts Ins(1,4,5)P3 to Ins(1,3,4,5)P4,
it has been proposed that InsP3K is involved in downregu-
lating IP3 receptor-mediated calcium signaling (Berridge,
1993; Schlossmann et al., 2000). Exposure of neutrophils
to chemoattractant leads to rapid increase in the concen-
tration of cytosolic calcium, which also plays an essential
role in activating NADPH oxidase. Therefore, the enhanced
superoxide production in InsP3KB-deficient neutrophils
could be a result of elevated calcium signaling. Accord-
ingly, we measured the intracellular calcium concentra-
tions in neutrophils. We found that the amplitude and the
shape of the fMLP-induced calcium curve were not altered
in the InsP3KB-deficient neutrophils, indicating that the
enhanced superoxide production was not caused by de-
fects of calcium signaling (Figure S7). Noticeably, a normal
calcium mobilization was also observed in InsP3KB-
deficient T cells (Pouillon et al., 2003; Wen et al., 2004).
The enhancement of superoxide production in
InsP3KB-deficient neutrophils can be blocked by increas-
ing intracellular Ins(1,3,4,5)P4 concentration (Figure 5H).
Treatment with membrane-permeant Ins(1,3,4,5)P4-AM,
but not Ins(1,4,5,6)P4-AM, inhibits fMLP-induced super-
oxide production in both wild-type and InsP3KB-deficient
neutrophils. This result further demonstrates that the
enhanced superoxide production in InsP3KB-deficient
neutrophils is a direct result of Ins(1,3,4,5)P4 depletion in
these neutrophils.
The responses of neutrophils to chemoattractant stimu-
lation can also be affected by the amount of receptor
expressed on the plasma membrane. In order to examine
whether there is an alteration in chemoattractant receptor
expression, neutrophils were incubated with FITC-fMLP in
the absence or presence of excess amount of unlabeled
fMLP. The specific binding of fMLP to the receptor was
expressed as the mean fluorescence intensity of cells in-
cubated in the absence of unlabeled fMLP subtracted by
the mean fluorescence intensity of cells incubated in the
presence of unlabeled fMLP. Our results show that nearly
the same amount of fMLP receptor was expressed in
InsP3KB-deficient and wild-type neutrophils (Figure S8).
Hence, the increased superoxide production in
InsP3KB-deficient neutrophils should be a direct conse-
quence of elevated PtdIns(3,4,5)P3 signaling.
InsP3KB-Deficient Neutrophils Exhibit
an Augmented Chemoattractant-Induced
Polarization and Chemotaxis
We have demonstrated that loss of InsP3KB results in
hyperactivation of PtdIns(3,4,5)P3 signaling and an in-Imcrease in total F-actin content. One cellular response
mediated by PtdIns(3,4,5)P3 and F-actin is membrane
ruffling and polarization. Therefore, we next investigated
the morphological changes of neutrophils in response to
chemoattractants. Both wild-type and InsP3KB-deficient
neutrophils were predominantly round before fMLP stimu-
lation (Figure 6A; Movies S1 and S2). When uniformly stim-
ulated with fMLP, cells in both wild-type and InsP3KB-
deficient displayed membrane ruffles and then polarized,
forming distinct psudopods and uropods. However, we
found that more InsP3KB-deficient neutrophils (Figures
6A and 6B; Movie S2) ruffled in comparison to WT cells
(Figures 6A and 6B; Movie S1). When we performed a
sensitivity analysis with different concentrations of fMLP,
we found that this difference was more apparent when
low concentrations of fMLP (<50 nM) was utilized. The dif-
ference became progressively smaller as the dose applied
was increased (Figure 6B), suggesting that both WT and
InsP3KB-deficient neutrophils are equally capable of
responding to high concentrations of chemoattractant
and that InsP3KB-deficient neutrophils are just more
sensitive to chemoattractant than WT neutrophils. The en-
hanced responsiveness of InsP3KB-deficient neutrophils
was also observed in a transwell chemotaxis assay. The
recruitment of circulating effector leukocytes, including
neutrophils, monocytes, and effector T cells to the sites
of injury or infection, is mediated by a process called che-
motaxis, in which cells sense and move up a gradient of
chemoattractants. A pathway mediated by PtdIns(3,4,5)P3
has been established as one of the essential chemotactic
signals (Gardiner et al., 2002; Ridley et al., 2003; Zigmond,
1989). Consistent with our hypothesis that Ins(1,3,4,5)P4
is a negative regulator of PtdIns(3,4,5)P3 signaling, the
chemotaxis of InsP3KB-deficient neutrophils was sub-
stantially improved when either fMLP or IL-8 was used as
a chemoattractant (Figures 6C and 6D). In comparison
to wild-type cells, InsP3KB-deficient cells are 31% and
46% more efficient in migration to fMLP and IL-8,
respectively.
Neutrophil Recruitment to Inflamed Peritoneal
Cavity Is Elevated in InsP3KB-Deficient Mice
Our in vitro experiments showed that InsP3KB null neutro-
phils displayed higher responsiveness to chemoattractant
stimulation. We next investigated whether this enhanced
responsiveness could lead to elevated neutrophil recruit-
ment at sites of inflammation in live InsP3KB-deficient
mice. We utilized a mouse acute peritoneal inflammation
(peritonitis) model to examine neutrophil recruitment (Fig-
ures 6E and 6F). Inflammation was induced by intraperito-
neal injection of E.coli 19138 (Figure 6E) or thioglycollate
(TG) (Figure 6F). TG is a polysaccharide mixture that has
been widely used for decades to induce a mild peritonitis,
yielding information about the early events of inflamma-
tion. Very few peritoneal neutrophils were detected inShown is the relative superoxide production, which is calculated as the percentage of superoxide production by untreated (DMSO only) neutrophils
(normalized to 100). Data are the mean (±SD) of three independent experiments. *p < 0.01 versus untreated (DMSO only) neutrophils by Student’s
t test.munity 27, 453–467, September 2007 ª2007 Elsevier Inc. 461
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Ins(1,3,4,5)P4 Function in NeutrophilsFigure 6. Disruption of InsP3KB Leads to Enhanced Sensitivity of Neutrophil to Chemoattractant Stimulation and Augmented
Chemotaxis
(A) Chemoattractant-elicited neutrophil polarization. Purified mouse neutrophils were plated in Labtek chamber and uniformly stimulated with 50 nM
fMLP. Shown are representative images of unstimulated (left) and 10 min stimulated (right) neutrophils. Two videos of the experiment described in this
figure are included in Supplemental Data (Movies S1 and S2).
(B) Sensitivity analysis. Neutrophils were uniformly stimulated with the indicated amount of fMLP. Percentage of polarized cells (extended pseudo-
pods or ruffled) after 10 min of stimulation was counted. *p < 0.01 versus wild-type neutrophils.
(C) Transwell migration toward fMLP was measured with calcein-AM-labeled cells. Percentage of cells that migrated from the top of the filter to the
bottom well was recorded.
(D) Transwell migration toward IL-8.
(E) Recruitment of neutrophils to peritoneal cavity in a E. coli-induced peritonitis model. Neutrophil recruitment was analyzed 4 hr after the injection.
(F) Recruitment of neutrophils in a Thioglycollate (TG)-induced peritonitis model. Neutrophil recruitment was analyzed 4 hr after injection. Data shown
are mean ± SD of n = 3 mice. *p < 0.01 versus wild-type neutrophils.unchallenged mice (Figures 6E and 6F). After induction of
inflammatory reactions, the number of neutrophils in the
wild-type peritoneal exudate reached nearly 1.8 3 106,
4 hr after bacteria injection. InsP3KB-deficient mice
showed a dramatic increase in bacteria-induced neutro-
phil recruitment—nearly 43106 neutrophils were recruited
to the peritoneal cavity, 4 hr after induction (Figure 6E).
A similar effect was detected when TG was injected. At
4 hr after TG injection, the number of neutrophils in the
peritoneal exudates was substantially higher in InsP3KB-
deficient in comparison to wild-type mice (Figure 6F).
Because we measured neutrophil numbers at 4 hr after
the injection when neutrophil spontaneous death has not
yet happened, the elevated neutrophil number in the peri-
toneal cavity most likely reflected the enhanced neutrophil
recruitment.
In the knockout mice utilized in this study, InsP3KB
gene was disrupted in all cell types. The detected aug-462 Immunity 27, 453–467, September 2007 ª2007 Elsevier Incmentation of neutrophil recruitment in Figures 6E and 6F
could also be a result of enhanced production of cytokine
and chemokine from mast cells or macrophages in perito-
neal cavity. To assure that elevated chemotactic signaling
in neutrophils is indeed directly involved in the augmenta-
tion of neutrophil recruitment, we conducted an adoptive
transfer experiment (Figure 7; Figure S9). We labeled
in vitro purified InsP3KB null neutrophils with intracellular
fluorescent dye 5-(and -6)-carboxyfluorescein diacetate
succinimidyl esters (CFSE) (green) and wild-type neutro-
phils with another dye, 5-(and -6)-chloromethyl SNARF-1
acetate (red), or vice versa. The mixed (1:1) population
was intravenously injected into a wild-type mouse 2.5 hr
after the intraperitoneal TG injection (Figure 7). By doing
this, we were able to compare the neutrophil recruitment
of these two types of neutrophils in exactly the same envi-
ronment. InsP3KB null (green) and wild-type (red) neutro-
phils were identified by their unique fluorescent labels..
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regulator of chemotactic signaling in neutrophils, we de-
tected a much enhanced peritoneal recruitment of
InsP3KB null neutrophils compared with wild-type neutro-
phils (Figure 7).
DISCUSSION
Recently, we demonstrated physiologic regulation of
Dictyostelium chemotaxis by InsP7 mediated by its com-
petition with PtdIns(3,4,5)P3 for binding PH domain-con-
taining proteins (Luo et al., 2003b). In the current study,
we described a similar mechanism in mammalian cells—
Ins(1,3,4,5)P4 competes for binding of the PH domains
to PtdIns(3,4,5)P3, and thus negatively regulates
PtdIns(3,4,5)P3-mediated neutrophil functions. This
model is also supported by crystallographic data, which
showed that several PtdIns(3,4,5)P3-specific PH domains
can form stable complexes with Ins(1,3,4,5)P4 (Ferguson
et al., 2000; Lietzke et al., 2000).
InsP7 and Ins(1,3,4,5)P4 are formed by InsP6Ks and
InsP3Ks, respectively. They have a similar potency in
inhibiting PtdIns(3,4,5)P3-PH domain binding (Luo et al.,
2002). In D. discoideum, chemoattractant stimulation rap-
idly augments InsP7, whereas the level of Ins(1,3,4,5)P4 is
undetectable (Van Dijken et al., 1994), which is consistent
with the fact that InsP3K occurs only in higher organisms
Figure 7. Recruitment of Adoptively Transferred Neutrophils
in the TG-Induced Peritonitis Model
Neutrophils isolated from WT and InsP3KB-deficient mice were la-
beled with intracellular fluorescent dye 5- (and -6)-carboxyfluorescein
diacetate succinimidyl esters (CFSE) or 5- (and -6)-chloromethyl
SNARF-1 acetate (SNARF-1). Labeled cells were mixed and then in-
jected intravenously into wild-type mice that have been challenged
with 1 ml 3% TG for 2.5 hr. The amount of adoptively transferred neu-
trophils recruited to the peritoneal cavity was analyzed 1.5 hr after the
injection. Relative recruitment of neutrophil was calculated as the ratio
of indicated populations in the peritoneal cavity (see Figure S9 for de-
tails). Data shown are mean ± SD of n = 3 mice. *p < 0.01 versus wild-
type neutrophils.Imsuch asDrosophila and mammals (Irvine and Schell, 2001;
Shears, 2004). Consistent with this, we did not detect any
Ins(1,4,5)P3 kinase activity in Dictyostelium (data not
shown). Thus, InsP7 acts as the major negative regulator
of PtdIns(3,4,5)P3-mediated chemotactic signaling in
D. discoideum. InsP7 also exists in mammalian cells and
has been implicated in several physiological processes
(Morrison et al., 2001; Nagata et al., 2005). However,
InsP7 is almost undetectable in mammalian neutrophils
even after the chemoattractant stimulation, suggesting
that it is not a major regulator in neutrophils. Instead, we
detected a high InsP3 kinase activity in neutrophils, and
chemoattractant stimulation triggers rapid elevations in
Ins(1,3,4,5)P4 concentrations, but not InsP7 concentra-
tion, suggesting that Ins(1,3,4,5)P4 plays a major role in
neutrophils.
There are three isoforms of InsP3K (InsP3KA, InsP3KB,
and InsP3KC) in mammalian cells (Choi et al., 1990; Dew-
aste et al., 2002; Nalaskowski et al., 2003). We showed
that InsP3KB is the major InsP3K isoform in neutrophils.
Disruption of the single InsP3KB gene in mouse com-
pletely abolishes Ins(1,3,4,5)P4 production in neutrophils.
InsP3KB also contributes to the majority of InsP3 kinase
activity in T cells and B cells. Recently, two independent
studies showed that disruption of InsP3KB led to dramat-
ically decreased cellular concentration of Ins(1,3,4,5)P4,
impaired T cell development, and impaired thymocyte
selection (Pouillon et al., 2003; Wen et al., 2004). Disrup-
tion of InsP3KB also induces B cell death and impaired
B cell development (Miller et al., 2007; Marechal et al.,
2007). InsP3K has been reported to be a potential modu-
lator of calcium mobilization, as indicated by the fact that it
can decrease the concentration of Ins(1,4,5)P3, which
mediates calcium release from internal store, by convert-
ing it to Ins(1,3,4,5)P4. Surprisingly, similar with what we
observed in neutrophils, no substantial defects in
Ins(1,4,5)P3 amounts or calcium mobilization was
detected in InsP3KB null T cells (Pouillon et al., 2003;
Wen et al., 2004), indicating that disrupting InsP3KB might
induce a calcium-independent alteration that is responsi-
ble for the detected phenotypes in InsP3KB null T cells
and neutrophils. Miller et al. recently reported that
Ins(1,3,4,5)P4 inhibits calcium influx by blocking store-
operated calcium channels and regulates B cell selection
and activation (Miller et al., 2007). However, we detected
a similar increase of superoxide production in InsP3KB
null neutrophils even in the presence of extracellular cal-
cium chelate EGTA (data not shown), suggesting that
the enhanced superoxide production in these neutrophils
is not a result of elevated calcium influx.
Consistent with the enhanced chemotactic signaling in
InsP3KB null neutrophils, we detected an augmented neu-
trophil recruitment to the inflamed peritoneal cavity in the
InsP3KB knockout mice. However, in the same model
system, the clearance of injected bacteria in the knockout
mice was not substantially enhanced (data not shown).
Bacteria killing at the sites of infection is a complex pro-
cess. In the InsP3KB-deficient mice utilized in this study,
the gene encoding InsP3KB was disrupted in all cell types.munity 27, 453–467, September 2007 ª2007 Elsevier Inc. 463
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decreased and the serum concentration of IgG, which is
essential for opsinization and phagocytosis, was also
reduced. This might lead to decreased phagocytosis of
bacteria by neutrophils and macrophages. In addition,
disruption of InsP3KB might impair various functions of
macrophages and/or mast cells that also play major roles
in bacteria killing.
In neutrophils, chemoattractant stimulation triggers
a potent and rapid elevation of Ins(1,3,4,5)P4, indicating
a regulation of Ins(1,3,4,5)P4 concentration by receptor
occupancy. The major metabolic pathway for generating
Ins(1,3,4,5)P4 is through Ins(1,4,5)P3 (Irvine, 1995; Irvine
and Schell, 2001). Ins(1,4,5)P3 is formed from the hydroly-
sis of PtdIns(4,5)P2 by phospholipase C (PLC or PI-PLC).
We examined fMLP-elicited Ins(1,4,5)P3 production in
neutrophils. As previously reported (Bradford and Rubin,
1986; Fruman et al., 1991), we detected a rapid chemoat-
tractant-elicited augmentation of Ins(1,4,5)P3 (data not
shown). Its concentration increases more than 10-fold in
the first 20 s after fMLP stimulation. This event occurs be-
fore the elevation of Ins(1,3,4,5)P4 concentration, sup-
porting the idea that Ins(1,4,5)P3 is the substrate for
Ins(1,3,4,5)P4 formation. Interestingly, in current study,
we found that the InsP3 kinase is not constitutively active.
Its activity in unstimulated neutrophils is relatively low. The
activity can be dramatically upregulated by chemoattrac-
tant stimulation. The low basal InsP3 kinase activity might
be necessary for chemoattractant-stimulated neutrophils
to generate or maintain the initial high concentration of
Ins(1,4,5)P3, which is essential for downstream calcium
signaling. Alternatively, the regulation of InsP3 kinase by
chemoattractant might simply be another mechanism for
finely tuning intracellular Ins(1,3,4,5)P4 concentration.
We did not detect any reduction of InsP5 and InsP6 con-
centration upon fMLP stimulation, which is consistent
with the previous reports that dephosphorylation of
InsP5 or InsP6 is not the major source for Ins(1,3,4,5)P4
production (Irvine and Schell, 2001; Shears, 2004). PLC-
b2 and PLC-b3 are the two major PLC isoforms activated
by G protein in neutrophils. Chemoattractant-elicited aug-
mentation of intracellular Ins(1,3,4)P3 and Ins(1,3,4,5)P4
were diminished in PLC-b2-b3 double-deficient neutro-
phils (Li et al., 2000). Interestingly, similar with the InsP3KB
null neutrophils, PLC-b2-b3 double-deficient neutrophils
also displayed an enhanced responsiveness toward che-
moattractant stimulation (Li et al., 2000). Jiang et al. mea-
sured the leukocyte accumulation in the thoracic cavity af-
ter an intrathoracic injection of methylated bovine serum
albumin. The PLC-b2-b3-deficient mice showed a more
dramatic increase in the number of thoracic leukocytes
in comparison to wild-type mice (Jiang et al., 1997). This
result supports our hypothesis that Ins(1,3,4,5)P4 is a neg-
ative regulator for chemotaxis and thereby for leukocyte
recruitment (Figure S10).
Several Ins(1,3,4,5)P4 binding proteins, including Ras
GTPase-activating protein GAP1IP4BP (also known as
Rasa3), GAP1m, and a-centaurin, also interact physiolog-
ically with inositol phospholipid (Cullen et al., 1995; Ham-464 Immunity 27, 453–467, September 2007 ª2007 Elsevier Incmonds-Odie et al., 1996), suggesting that the functions of
these proteins might be regulated by Ins(1,3,4,5)P4 via
a similar mechanism as described in this study. Recently,
researchers showed that Ins(1,3,4,5)P4 competes for
binding of the PH domain of Rasa3 to PtdIns(4,5)P2 and
thus negatively regulates PtdIns(4,5)P2-mediated Rasa3
plasma membrane translocation and activation in B cells.
Rasa3 is a GTPase-activating protein acting on Ras that
can subsequently regulate the expression of a proapop-
totic factor, Bim. Disruption of InsP3KB in B cells leads
to depletion of intracellular Ins(1,3,4,5)P4, enhanced
plasma membrane translocation and activation of
Rasa3, decreased Ras-Erk activation, and thus elevated
Bim expression, which in turn causes enhanced cell death
and impaired development of InsP3KB null B cells (Mare-
chal et al., 2007). Rasa3-mediated cell survival appears
not to be a prominent mechanism in neutrophils because
this gene is barely expressed in neutrophils. In another
very recent report, Huang et al. showed that
Ins(1,3,4,5)P4 can also bind to the PH domain of Itk. Inter-
estingly, this binding changes the conformation of Itk PH
domain and subsequently promotes the PH domain bind-
ing to PtdIns(3,4,5)P3 in T cells (Huang et al., 2007).
Whether a similar mechanism also exists in neutrophils
has not been investigated.
In our current study, we showed that Ins(1,3,4,5)P4 acts
as a negative regulator of neutrophil function and its intra-
cellular concentration is upregulated by chemoattractant
receptor activation. Why do neutrophils need this negative
regulator? Neutrophil accumulation and activation at in-
flammatory sites is an important component of the innate
immunity and is required for the host’s ability to kill invad-
ing pathogens. However, hyperactivation of neutrophils
can also damage the surrounding tissues via the release
of toxic reactive oxygen species and granule enzymes
such as proteases, leading to acute inflammation. There-
fore, neutrophil activity needs to be accurately controlled
by both positive and negative regulators. Ins(1,3,4,5)P4
could be a good candidate for such a negative regulator.
Ins(1,3,4,5)P4 and other components responsible for
modulating Ins(1,3,4,5)P4 concentration (e.g., InsP3KB)
may be utilized as therapeutic targets for modulating neu-
trophil responses, which need to be enhanced to facilitate
their pathogen-killing capability and suppressed to aid the
resolution of inflammation.
EXPERIMENTAL PROCEDURES
Mice
InsP3KB-deficient mice were generated as previously described
(Pouillon et al., 2003). Mice aged 8–14 weeks were used in this study.
We always utilized wild-type littermates as experimental controls. All
animal manipulations were conducted in accordance with the Animal
Welfare Guidelines of Children’s Hospital. All procedures were
approved and monitored by the Children’s Hospital Animal Care and
Use Committee.
Isolation of Human and Murine Neutrophils
Human peripheral blood neutrophils were isolated from healthy donors
as previously described (Subramanian et al., 2007; Zhu et al., 2006).
The purity of neutrophils was >97% as determined by both.
Immunity
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Mouse neutrophils were prepared from the femur and tibia of 8- to
14-week-old mice as previously described (Subramanian et al., 2007).
Each preparation yielded about 5–15 million neutrophils (per mouse)
with a purity of more than 90% by Wright-Giemsa staining and FACS
analysis with double staining with Gr-1 and CD11b monoclonal
antibodies (Figure S5).
HPLC Analysis of Inositol Phosphates in Differentiated
HL60 Cells
HL60 cells were cultured in RPMI-1640 medium supplemented with
10% FBS and 4 mM glutamine. For differentiation, cells were plated
at a density of 3 3 106 cells/ml and treated with DMSO (1.3%, v/v)
for 6 days. At the same period, [3H]inositol (100 mCi/ml) was added
into the medium to label endogenous inositol phosphates. Cells
were stimulated with 100 nM fMLP, and aliquots of cells (1 ml or 3 3
106 cells) were lysed at indicated time points. The inositol phosphates
were extracted and analyzed by HPLC as previously described (Luo
et al., 2001).
Coimmunoprecipitation of Inositol Phosphates
with PHAkt-GFP
HL60 cells stably expressing PHAkt-GFP were differentiated and
labeled with [3H]inositol as described above. Coimmunoprecipitation
of inositol phosphates with GFP antibody was conducted as previously
described (Luo et al., 2001).
Neutrophil Function Assays
Chemoattractant-elicited polarization assay, actin polymerization
assay, micropipette chemotaxis assay, transwell chemotaxis assay,
and superoxide production assay were all performed as previously
described (Subramanian et al., 2007).
Recruitment of Neutrophils in E. coli or Thioglycollate
Peritonitis
Peritonitis was induced as previously described (Subramanian et al.,
2007). Mice were euthanized by CO2 inhalation 4 hr after E. coli or
thioglycollate (TG) injection, and peritoneal exudate cells were recov-
ered by peritoneal lavage with 10 ml of ice-cold PBS containing
5 mM EDTA. The total amount of cells was counted by hemocytome-
ter. The percentage of neutrophils in the whole population (%PMN)
was determined by morphology identification of neutrophils in cyto-
spun cells or FACS analysis of cells stained with PE-CD11b and
FITC-Gr-1 antibodies. Total number of neutrophils (#PMN) recruited
was calculated as follows: [#PMN] = [cell density] 3 volume 3
[%PMN].
Statistical Analysis
All comparisons were made by a two-tailed, unpaired, Student’s t test,
unless otherwise specified. A p value% 0.05 was considered statisti-
cally significant.
Supplemental Data
Ten figures, four movies, and Experimental Procedures are available at
http://www.immunity.com/cgi/content/full/27/3/453/DC1/.
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